TY  - GEN
AU  - Epaillard, Nicolas
AU  - Parent, Pauline
AU  - Loriot, Yohann
AU  - Lavaud, Pernelle
AU  - Vera-Cea, E-B.
AU  - Martinez-Chanza, Nieves
AU  - Rodriguez-Vida, Alejo
AU  - Dumont, Clement
AU  - Lozano, Rebeca
AU  - Llácer, Casilda
AU  - Ratta, Raffaele
AU  - Oudard, Stephane
AU  - Thibault, Constance
AU  - Auclin, Edouard
PY  - 2021
DO  - 10.3389/fonc.2021.671969
UR  - http://hdl.handle.net/20.500.12105/18352
AB  - Introduction: Less than one-third of bladder cancers are non-pure urothelial carcinoma [with variant histological (VH) or non-urothelial carcinoma (non-UC)] for which no treatment guidelines are available. We aim to evaluate the efficacy of systemic...
LA  - eng
PB  - Frontiers Media
KW  - Urinary bladder neoplasms
KW  - Variant histology
KW  - Drug therapy
KW  - Immunotherapy
KW  - Mortality
KW  - Neoplasias de la vejiga urinaria
KW  - Quimioterapia
KW  - Inmunoterapia
KW  - Mortalidad
KW  - Humans
KW  - Female
KW  - Carcinoma, Transitional Cell
KW  - Urinary Bladder Neoplasms
KW  - Platinum
KW  - Confidence Intervals
KW  - Immunotherapy
KW  - Drug Therapy
TI  - Treatments Outcomes in Histological Variants and Non-Urothelial Bladder Cancer: Results of a Multicenter Retrospective Study
TY  - research article
ER  -